While many dietary supplements have been widely promoted as providing safe and reliable relief from menopausal symptoms, it is important for women and their doctors to consider using only those dietary supplements that have undergone rigorous clinical and safety trials, typically presented in peer-reviewed scientific literature.
At Amberen, our users’ safety remains our top priority. Amberen's safety and effectiveness has been evaluated in rigorous clinical trials and is backed by over 45 years of research on its main ingredient.
Pre-clinical and clinical studies have shown that Amberen was found to be a safe and well-tolerated dietary supplement. Evaluation of the clinical and laboratory safety parameters, such as vital signs, blood tests, and urinalysis, did not reveal any differences between Amberen and placebo groups.
More than that, no adverse reactions were observed in the Amberen groups during the course of the studies.
Animal testing acute toxicity and genotoxicity found Amberen to be a safe dietary supplement.
Ammonium succinate – Amberen's main ingredient – was subject to toxicity studies in animals and was found to be safe.